Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05469282
Status:
COMPLETED
Last Update Posted:
2023-01-09
First Post:
2022-07-19
Brief Title:
CEFID-I CEra Flow Improves DVT-1
Sponsor:
Ceragem Clinical Inc
Organization:
Ceragem Inc
Study Overview
Official Title:
A Single Center Clinical Trial to Evaluate the Efficacy and Safety of Blood Circulation Improvement Using an Investigational Medical Device Model Name CGM MB-1701 for the Risk Group of Deep Vein Thrombosis DVT and the Ordinary Person
Status:
COMPLETED
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is a single center clinical trial to evaluate the efficacy and safety of blood circulation improvement using an investigational medical device which is a product on the market and its name is Ceragem Master V6 for the risk group of Deep Vein Thrombosis DVT and the ordinary person The study compares before and after the application by one time application
Detailed Description:
The efficacy and safety evaluation are conducted before and after or during the application of the test device The investigator shall apply an investigational device once when visiting a suitable subject for one day
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None